Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 589.2 DKK -20.72% Market Closed
Market Cap: 2.6T DKK
Have any thoughts about
Novo Nordisk A/S?
Write Note

Wall Street
Price Targets

NOVO B Price Targets Summary
Novo Nordisk A/S

There are no price targets for NOVO B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novo Nordisk A/S Competitors:
Price Targets
SUNPHARMA
Sun Pharmaceutical Industries Ltd
12% Upside
GLENMARK
Glenmark Pharmaceuticals Ltd
7% Upside
IPN
Ipsen SA
20% Upside
4577
Daito Pharmaceutical Co Ltd
41% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
32% Upside
BMY
Bristol-Myers Squibb Co
5% Upside
PHO
Photocure ASA
59% Upside
214370
Caregen Co Ltd
47% Downside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 10%. The projected CAGR for the next 4 years is 16%.

10%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 11%. The projected CAGR for the next 4 years is 17%.

11%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 12%. The projected CAGR for the next 4 years is 18%.

12%
Past Growth
18%
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVO B's stock price target?
Not Available

NOVO B doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 10%. The projected CAGR for the next 4 years is 16%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 11%. The projected CAGR for the next 4 years is 17%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 12%. The projected CAGR for the next 4 years is 18%.

Back to Top